Angelo Schenone
Angelo Schenone
Professor of Neurology, University of Genova
Verified email at - Homepage
Cited by
Cited by
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2.
MAP Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM ...
Nat Genet 25 (1), 17-19, 2000
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease
A Niemann, M Ruegg, V La Padula, A Schenone, U Suter
The Journal of cell biology 170 (7), 1067-1078, 2005
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ...
Annals of Oncology 24 (2), 454-462, 2013
Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
D Pareyson, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, L Santoro, ...
The Lancet Neurology 10 (4), 320-328, 2011
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
V Fridman, B Bundy, MM Reilly, D Pareyson, C Bacon, J Burns, J Day, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (8), 873-878, 2015
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
E Nobile-Orazio, D Cocito, S Jann, A Uncini, E Beghi, P Messina, ...
The Lancet Neurology 11 (6), 493-502, 2012
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ...
The Lancet Neurology 17 (1), 35-46, 2018
Sonography of the median nerve in Charcot-Marie-Tooth disease
C Martinoli, A Schenone, S Bianchi, P Mandich, C Caponetto, ...
American Journal of Roentgenology 178 (6), 1553-1556, 2002
Insulin‐like growth factor‐I prevents apoptosis in neurons after nerve growth factor withdrawal
JW Russell, AJ Windebank, A Schenone, EL Feldman
Journal of neurobiology 36 (4), 455-467, 1998
Regional variation of Guillain-Barré syndrome
AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ...
Brain 141 (10), 2866-2877, 2018
Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study
G Cavaletti, A Beronio, L Reni, E Ghiglione, A Schenone, C Briani, G Zara, ...
Neurology 62 (12), 2291-2293, 2004
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ...
Annals of oncology 25 (1), 257-264, 2014
Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside
J Li, Y Bai, K Ghandour, P Qin, M Grandis, A Trostinskaia, E Ianakova, ...
Brain 128 (5), 1168-1177, 2005
Peripheral nerves: a target for the action of neuroactive steroids
RC Melcangi, ITR Cavarretta, M Ballabio, E Leonelli, A Schenone, ...
Brain research reviews 48 (2), 328-338, 2005
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature
L Benedetti, C Briani, D Franciotta, R Fazio, I Paolasso, C Comi, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (3), 306-308, 2011
Predictors of response to rituximab in patients with neuropathy and anti–myelin associated glycoprotein immunoglobulin M
L Benedetti, C Briani, M Grandis, T Vigo, M Gobbi, E Ghiglione, M Carpo, ...
Journal of the Peripheral Nervous System 12 (2), 102-107, 2007
Loss of large-diameter spindle afferent fibres is not detrimental to the control of body sway during upright stance: evidence from neuropathy
A Nardone, J Tarantola, G Miscio, F Pisano, A Schenone, M Schieppati
Experimental brain research 135 (2), 155-162, 2000
Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract
F Zara, R Biancheri, C Bruno, L Bordo, S Assereto, E Gazzerro, F Sotgia, ...
Nature genetics 38 (10), 1111-1113, 2006
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database
PE Doneddu, D Cocito, F Manganelli, R Fazio, C Briani, M Filosto, ...
Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 125-132, 2019
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis
GL Mancardi, A Murialdo, P Rossi, F Gualandi, G Martino, A Marmont, ...
Multiple Sclerosis Journal 11 (3), 367-371, 2005
The system can't perform the operation now. Try again later.
Articles 1–20